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ABSTRACT Key Words
We have previously shown that sera from patients
with Alzheimer’s disease (AD) contain a significantly
high level of antibodies to the cell bodies (Perikarya;
PK) but not to the nerve terminals (synaptosomes)
of purely cholinergic neurons from the electric fish
Torpedo. In the present study we examined the effect
of repeated immunization of rats with either of these
antigens for one year. Immunoblot studies revealed
that sera of cholinergic PK immunized rats contained
a high level of antibodies to cholinergic PK proteins,
in particular to a 200 kilodalton protein, to which
there are specifically high levels of antibodies in AD.
Sera from rats immunized with cholinergic synapto-
somes and from control rats contained very low levels
of these antibodies. Behavioral studies performed
one year after the initial immunization revealed that
the cholinergic PK immunized rats were impaired
in spatial learning and memory tasks (Morris swim
test and T-maze alternation) when compared to con-
trol rats and that the synaptosome-immunized rats
showed no such deficit. In contrast, the three groups
performed similarly in general activity, active avoid-
ance and conditioned emotional response tests. Fur-
ther experiments revealed that the cholinergic PK
immunized rats displayed a significant deficit in short
term memory. The association of antibodies to choli-
nergic neurons with cognitive deficits in this rat model
suggests that such antibodies may be involved in the
pathogenesis of AD.
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INTRODUCTION
Alzheimer’s disease (AD), the most common cause
of dementia, is associated with degeneration of choli-
nergic neurons in the basal forebrain which provide
most of the cholinergic input to the cortex and hippo-
campus /7, 33/. The severity of these degenerative
changes correlates with the cognitive impairment in
AD /2/. The extent of the cholinergic deficit, its oc-
currence early in the disease, its correlation with the
cognitive deficit in AD /12/ and the known role of
cholinergic mechanisms in higher cognitive functions,
particularly memory /1, 18/, all indicate a central
role for cholinergic degeneration in the pathogenesis
of AD.
Although the etiology and pathogenesis of the
cholinergic degeneration in AD are not known /31/,
several reports implicate immunological mechanisms
/5, 9, 14, 21, 26, 28, 34, 35, 39/. We have recently
shown that sera of AD patients contain antibodies
(IgG) which bind to specific constituents of choli-
nergic neurons and that these antibodies bind to choli-
nergic cell bodies but not to cholinergic nerve termi-
nals /3/. This study employed as antigen the purely
cholinergic electromotor neurons of the electric fish
Torpedo which are chemically homogeneous and con-
tain many constituents which cross react antigenically
with human and other mammalian cholinergic pre-
parations /18, 27, 28, 38/. Further immunoblot ex-
periments revealed that the AD IgG’s bind to a spe-
cific 200 kilodalton (kD) protein in the cell bodies
and axons of the Torpedo cholinergic neurons and
that the presence of such antibodies is specific to AD
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somes (1 mg protein/ml)were heated to 95C for
5 minutes in 100 mM Tris buffer, pH 6.8, which
contained 1.8% SDS (w/v) and 3% mercaptoethanol
(v/v). Polypeptides were separated by electrophoresis
on 12x15 cm 10% SDS-polyacrylamide gels (50
protein/lane) utilizing a Biorad Protean II Slab Cell
(50 mA for 2.5 hours) /17/. The separated polype0tides
were then transferred electrophoretically to nitro-
cellulose membranes (Biorad Trans-blot Cell at 100V
for 2h) /37/. Sera to be tested were incubated with
the nitrocellulose sheets and the bound IgG was de-
tected with peroxidase conjugated anti-rat IgG as pre-
viously described /4/. The molecular weights of poly-
peptides on the SDS-polyacrylamide gels and following
the immunoblot assay were determined from the po-
sition of marker proteins of known molecular weight.
Proteins were visualized with either Coomassie Blue
(SDS-polyacrylamide gels) or Ponceau S (nitrocellulose
strips).
The behavioral tests are described in the order in
which they were performed.
Morris Swim Test
Subjects: Eleven rats immunized with cholinergic
PK, 11 rats immunized with cholinergic synaptosomes
and 12 controls entered and completed the experi-
ment.
Apparatus: The apparatus consisted of a large
circular pool (240 cm diameter x 45 cm high)filled
with water to a depth of 30 cm. The water was ren-
dered opaque by the addition of 6 liters fresh milk.
All parts of the pool not covered by water were painted
white. A small white plastic platform (10xl0 cm)
weighted down by a metal base was always present
at the center of the southeast quadrant 30 cm from
the wall of the pool. The platform was submerged
cm beneath the surface of the milky water and was
not visible from just above water level. A variety of
extra-maze cues surrounded the maze and were avail-
able for the rats to utilize in locating the escape plat-
form.
Procedure: On each trial the rat was placed into
the water close to and facing the wall of the pool in
one of 4 equally spaced locations. The rat was allowed
to swim freely in the pool until it found the platform,
onto which it would promptly climb to escape from
the water. If a rat failed to locate the platform within
120 sec, it was placed there by the experimenter. The
intertrial interval was 30 sec, during which the rat
remained on the platform. Each rat received 4 trials
per day for 5 days. Within each block of four trials,
the rat was released at each of the starting locations,
but the sequence of locations was randomized across
rats and days. On each trial the latency to escape onto
the platform was measured by a stopwatch.
Data analysis: The times to reach the platform
for each trial were subjected to logarithmic transforma-
tion to allow the use of an ANOVA. Data analysis
included a main factor of treatment (cholinergic PK,
cholinergic synaptosomes and control)and repeated
measurements factors of days (5) and trials (4).
LocomotorA ctivity
SubJects: The subjects were the same used in the
Moris swim test.
Apparatus and procedure: Locomotor activity
was measured using three activity cages measuring
51x24x21 cm. Animals crossings were detected by
a Rockwell-Aim-65 microprocessor. Rats were indi-
vidually placed in the cages for 50 min and their cross-
ings were recorded every 5 min. Thus for each subject
10 data points were taken. All testing was conducted
between 9 a.m. and 5 p.m. The testing order of the
three experimental groups was counterbalanced. Data
were analyzed using an ANOVA with a main factor
of treatment (cholinergic PK, cholinergic synaptosomes
and controls) and a repeated measurements factor of
10 successive 5 min samples.
Conditioned Emotional Response (CER)
Subjects: Eleven rats immunized with cholinergic
PK, 11 rats immunized with cholinergic synaptosomes,
and 12 controls entered the experiment. Two rats
immunized with cholinergic synaptosomes and con-
trol rat died during the experiment and an additional
3 PK rats, 4 synaptosomes rats and control rat failed
to acquire the drinking response and were excluded
from the test. Results of 8 rats immunized with choli-
nergic PK, 5 rats immunized with cholinergic synapto-
somes, and 10 controls were therefore included in the
analysis.
Apparatus: The apparatus consisted of two plastic
test chambers set in a ventilated sound-insulated Grason-
Stadler Research Chest (Model 1101). The internal
dimensions of each chamber were 15x20x17 cm, as
measured from the raised grid floor. The chambers
were flat gray, with small holes drilled in the side for
ventilation. A drinking bottle could be inserted into
the chamber. When the bottle was not present, the
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hole was covered by a plastic lid. Licks were detected
by a drinkometer circuit. The conditioned stimulus
was a 5 s, 2.8 kHz tone produced by a Sonalert module
(Model SC628). The shock grid was made from stainless
steel bars 0.25 cm in diameter with 1.5 cm intervals.
Shock was supplied by a Grason-Stadler scrambled
shock source (Model E 1064GS)set at mA, s dura-
tion). A Rockwell AIM-65 microprocessor was used
for equipment programming and data recording.
Procedure: Rats were placed on a 23-h water de-
privation schedule one day prior to and throughout
the experiment. The stages of the CER procedure
were as follows: 1) Base-line. On each of the 10 days,
rats were individually placed into the experimental
chamber and allowed to make 600 licks. Each subject
was then returned to its home cage and allowed access
to water for 60 min. 2) Conditioning. On day
(following the l0 base-line days), with the water bottle
removed, each animal was given one tone-shock pairing.
Tone parameters were 5 sec duration and 2.8 kHz
(see apparatus). The mA, sec shock immediately
followed tone termination. The tone-shock pairing
was given 5 min after the start of the session. After
the pairing, animals were left in the experimental cham-
ber for an additional 5 min. 3) Test. On day 12 each
animal was placed in the chamber and allowed to drink
from the bottle. When the subject completed 90 licks
the tone was presented. The tone continued until
ten additional licks were completed. If the subject
failed to complete the last ten licks within 300 sec,
the session was terminated and a score of 300 was
recorded. The times between licks 80-90 and 90-100
were recorded.
Data analysis." Two one way ANOVA were per-
formed on the times between licks 80-90 (before
the presentation of the conditioned stimulus)and
the time to complete licks 90-100 (when the con-
ditioned stimulus was presented).
Avoidance
Subjects: Eleven cholinergic PK rats, 9 cholinergic
synaptosomes rats, and 11 controls entered the ex-
periment. One cholinergic synaptosomes rat and 2
control rats died during the course of the experiment
and their results were not included. Analysis was there-
fore performed on results from 11 rats immunized
with cholinergic PK, 8 immunized with cholinergic
synaptosomes, and 9 controls.
Apparatus: The two-way active avoidance appa-
ratus consisted of four identical Campden Instruments
shuttle boxes, measuring 48.5x23x20 cm. The barrier
between the two compartments of the box consisted
of an aluminum wall, with a central inverted U-shaped
gate (10x7 cm). Each box was set in a ventilated, sound-
insulated chest. The conditioned stimulus was a 5-sec,
2.8 kHz tone produced by a Sonalert module (Model
SC 628). Shock was supplied to the grid floor by a
Campden Instruments scrambled shock generator
(Model 521C) set at mA intensity. A micro-Vax
mini-computer was used for equipment programming
and data recording.
Procedure: Each animal was placed in the shuttle
box with the house lights on and received 20 avoidance
trials, presented on a variable interval 60-sec schedule
ranging from 30 to 90 sec. Each avoidance trial started
with a 5-sec tone followed by a 30-sec shock, the tone
remaining on with the shock. If the animals crossed
the barrier to the opposite compartment during the
5-sec tone, the tone was terminated and no shock
was delivered. A crossing response during shock ter-
minated the tone and the shock. If the animal failed
to cross during the entire tone-shock trial, the tone
and the shock terminated automatically after 35 sec.
The animals received 10 such days of avoidance acqui-
sition.
Analysis: The 200 trials were divided into 10 days
of 20 trials, and all analyses were carried out on the
percentage of avoidance on each of the ten 20-trial
blocks, with days as a repeated measurements factor.
T-Maze Alternation
Subfects: Eleven cholinergic PK rats, 8 cholinergic
synaptosomes rats and 9 controls entered the experi-
ment. In addition 2 cholinergic PK rats, 3 cholinergic
synaptosomes rats and 2 control rats failed to acquire
the running response and were excluded from the
test. Analysis was therefore performed on results from
6 cholinergic PK rats, 4 cholinergic synaptosomes rats
and 7 controls.
Apparatus: The T-maze was built of unoainted
wooden planks 9.5 cm wide with an edge about 0.7 cm
high along each side. The stem of the T was 80 cm
long, and the cross-piece was 136 cm long. A guillotine
door was located 34.5 cm from the beginning of the
stem. At each end of the cross-piece was a hole, 3.8 cm
in diameter and 0.7 cm deep, which served as a food
cup. The maze was supported by legs 30 cm long,
and placed on a table in a small, irregularly shaped
room which contained a variety of other objects, and
was illuminated by fluorescent ceiling lights.
JOURNAL OF NEURAL TRANSPLANTATIONIMMUNIZATION OF RATS WITH CHOLINERGIC NEURONS INDUCES BEHAVIORAL DEFICITS 67
Procedure: Rats were handled daily for at least
a week before the test. There were 5 days of pretrain-
ing. For the first 2 days, rats were placed on the maze
in pairs for about 20 min with 45 mg Campden Instru-
ments food pellets scattered along the cross-piece,
and with the guillotine door raised. For the next 2
days, the rats were placed on the maze singly for about
15 min, with the majority of the food located in the
food cups; the guillotine door was repeatedly raised
and lowered. On the fifth day two food pellets were
placed in each food cup. Each rat was placed at the
beginning of the start arm twice, and allowed to go
to each of the food cups and eat the food there.
During acquisition, the rats were given 8 trials each
day, each consisting of two runs through the maze.
On each trial four food pellets were placed in each
food cup, and a wooden block was placed on one
arm close to the choice point, blocking off the access
to that arm. On the information run the rat was olaced
at the starting point, the guillotine door was raised,
and the rat allowed to go to the available arm and
eat the food there. No retracing was permitted. The
rat was then picked up and returned to the starting
point and the wooden block was removed. The choice
run followed. The guillotine door was raised, and the
rat permitted to choose between the two arms. The
rat was deemed to have made a choice when it placed
a back foot on the choice arm. After each choice,
the wooden block was placed behind the rat so that
no retracing or correction was allowed. If the rats
chose the arm not visited on the forced run, it was
allowed to eat the food and was then removed from
the maze. If the other arm was chosen, the rat was
confined to the arm for approximately 10 sec and
was then returned to its holding cage. The rats were
tested in groups of 4, with each rat having one trial
in turn, giving a typical inter-trial interval of 2-5 min,
which was spent in a holding cage near the maze. The
arm to which the rat was directed for the information
run varied from trial to trial, with the constraints that
the same arm was not used for more than two con-
secutive trials and that each arm was used an equal
number of times on any day.
Data Analysis: The analysis consisted of an ANOVA
performed on the mean daily correct choices of each
animal and included one main factor of treatment
(cholinergic PK, cholinergic synaptosomes and control)
and a repeated measurements factor of days.
RESULTS
Immunological Studies
The levels of antibodies to homogenates of purified
Torpedo cholinergic PK and to cholinergic synapto-
somes in rats immunized with either cholinergic PK
or cholinergic synaptosomes were determined by means
of an enzyme linked immunoassay (ELISA) two months
following the initiation of immunization. The level
of anti-cholinergic PK antibodies in all the cholinergic
PK immunized rats (n 10) was high with end titration
points at serum dilations above 1:12,800. Half maxi-
mal antibody binding was obtained at serum dilutions
of 1:1000. Rats immunized with cholinergic synapto-
somes (n 10) had high levels of anti-cholinergic synap-
tosomes antibodies with titration end points at sera
dilutions above 1:25,600 and half maximal antibody
binding at sera dilutions of 1:2000. Bimonthly mea-
surements of the average levels of anti-cholinergic
PK antibodies in the PK immunized rats and of anti-
cholinergic synaptosomes antibodies in the synapto-
somes immunized rats revealed that they did not vary
significantly for up to one year. Thus, in both groups
maximal antibody levels were already reached two
months after the initial immunization. The anti-choli-
nergic PK and anti-cholinergic synaptosomes antibodies
in sera of control rats were low at all time points and
reached background levels at sera dilutions of less
than 1:2000.
The Torpedo polypeptides against which the rat
antibodies are directed were identified by means of
immunoblot assays. Since we have previously shown
that AD patients have high levels of antibodies to
Torpedo cholinergic PK and not to cholinergic synap-
tosomes /3, 4/ the experiment focused on the cha-
racterization of the anti-Torpedo cholinergic PK anti-
bodies in the immunized rats. Immunoblot results
utilizing electrophoresed cholinergic PK as antigen
and sera (dilution 1:500)of 4 rats immunized for
a year with either cholinergic PK, cholinergic synap-
tosomes or adjuvant are presented in Figure 1. As
can be seen IgG from rats immunized with cholinergic
PK interacted with more antigens than did those of
rats imlnunized with synaptosomes or those of con-
trol rats. Examination of the immunblots revealed
that 3 cholinergic PK rats contained IgG which bound
to a polypeptide of molecular mass of approxima-
tely 200 kilodalton (kD), whereas none of the choli-
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nergic synaptosomes immunized rats and none of
the control rats had such IgGs. In addition, the choli-
nergic PK rats contained IgG which bound to proteins
with molecular masses of 20 and 26 kD (Fig. 1). Exa-
mination of larger groups of rats revealed that 12 of
15 rats immunized with cholinergic PK had antibodies
to the 200 kD protein whereas only 2 of the 12 rats
immunized with cholinergic synaptosomes and none
of the 13 controls tested had any such antibodies.
Mol. wt.
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Fig. 1. Immunoblot assay of IgG directed against Torpedo
cholinergic perikarya in sera of 4 rats immunized
with cholinergic perikarya (PK), 4 rats immunized
with Torpedo cholinergic synaptosomes (SYNAPT)
and 4 control rats immunized with adjuvant alone.
The assay was performed utilizing rat sera (dilution
1:500) and blots of electrophoresed Torpedo choli-
nergic perikarya as described in Experimental Pro-
cedures. The right lane is a coomassie blue stain
of Torpedo cholinergic perikarya polypeptides fol-
lowing SDS-polyacrylamide gel electrophoresis. The
molecular weight scale was generated utilizing marker
proteins of known molecular weight.
Antibodies to the 200 kD Torpedo cholinergic poly-
peptide are a prominent feature of sera from AD pa-
tients. We therefore excluded the small number of
cholinergic PK rats with no such antibodies from the
behavioral tests.
The three groups of rats weighed the same at the
beginning of the experiment [314 + 26, 329 + 30,
and 318 + 31 g for respectively cholinergic PK, choli-
nergic synaptosomes and control rats; (mean + SD)].
Their weight increased during the first 6 months fol-
lowing the initial immunization (respectively 509 +- 38,
509 + 35 and 501 + 45 g) and were virtually unchanged
during the subsequent 8 months (respectively 532 48,
535 +_51 and 537 + 57 g). An analysis of variance
revealued no significant differences in the weights
of the 3 treatment groups (F’s < 1), nor were any
gross behavioral differences observed between these
groups.
Behavioral Studies
The tests included place navigation in a Morris
swim maze and a T-maze alternation test:, both of
which involve spatial memory tanks, a general motor
activity paradigm, an active avoidance test and a con-
ditioned emotional response test. The results of these
tests are presented in the order in which they were
performed.
Morris Swim Test
Fig. 2 presents the course of acquisition expressed
as the daily mean log times for the 3 experimental
groups (rats immunized with cholinergic PK n 11;
Cholinergic synaptosomes n 11; and controls n 12).
50
20
10-
9-
8-
6,
MORRIS MAZE
I, ,I
2 3 4 5
DAYS OF AQUISITION
Fig. 2. Daily means (4 trials/day) of logarithmically trans-
formed escape latencies in a Morris swim maze of
rats immunized for a year with Torpedo cholinergic
perikarya (e) (n 11), Torpedo cholinergic synap-
tosomes (&)(n 11) and adjuvant alone (o) (n
13).
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As can be seen the 3 groups acquired the swimming
response i.e. exhibited shorter response latencies as
acquisition progressed. This was supported by the
significant main effect of days (F 44.43 df 4/124
p < 0.001) and trials (F 12.46 df 3/93 p < 0.001).
Inspection of Fig. 2 also reveals that whereas the con-
trol and cholinergic synaptosomes groups acquired
the response in a similar manner the cholinergic PK
group was deficient throughout acquisition. This was
supported by the significant main effect of treatment
(F 3.28 df 2/31 p --0.05). The main effect of
treatment was not in interaction with either days or
trials (F’s < 1) indicating that a deficit existed through-
out the acquisition phase.
Locomotor Activity
Figure 3 presents the mean number of crossings
during successive 5 minute samples of the 50 minute
session of the 3 treatment groups (cholinergic PK,
n 11 cholinergic synaptosomes, n 11 and controls,
n 12). As can be seen there was a significant decline
in the number of crossings over the 10 sample periods
which was supported by the significant main factor
of samples (F 100.27 df 2/88 p < 0.001). How-
ever neither the main effect of treatment nor the inter-
action of treatment x sample were significant (F < 1).
Conditioned Emotional Response
Table summarizes the average times of the three
groups (cholinergic PK, n 8; cholinergic synapto-
somes, n 5; and controls, n 10) to complete the
10 licks before and the 10 licks after the presentation
of the conditioned stimulus. Analysis of the times
to complete licks 80-90 (before the presentation
of the conditioned stimulus) revealed a significant
main effect of treatment (F 4.03 df 2/20 p < 0.04).
This effect reflects the slower times of the rats im-
munized with cholinergic synaptosomes as compared
with the control and cholinergic PK groups (Table 1).
TABLE
CONDITIONED EMOTIONAL RESPONSE OF RATS
IMMUNIZED WITH TORPEDO CHOLINERGIC PERIKARYA,
SYNAPTOSOMES AND CONTROLS
Controls Cholinergic Cholinergic
Perikarya Synaptosomes
Time to
complete
licks 80-90 2.06 + 0.72 2.24 + 0.92 4.06 + 2.58
Time to
complete
licks 90-100 109.14 + 133.9 135.29 + 144.7 103.97 + 121.77
ACTIVITY
11
,I 0 2 3 4 6 7 8 9 I0
5 MINUTE SAMI::ES
F.ig. 3. Locomotor activity expressed as mean number of
crossings during 10 five minute periods of rats im-
munized for a year with either Torpedo cholinergic
perikarya (e) (n 11), Torpedo cholinergic synap-
tosomes (&) (n 11) or adjuvant alone ((C)) (n
13).
Rats were immunized for one year with purified cholinergic
perikarya (n 8), cholinergic synaptosomes (n 5) and ad-
juvant (controls, n 9), after which they were subjected to
a conditioned emotional response test performed as described
in Experimental Procedures. Results presented are the mean
time + SD for the 3 treatment groups to complete 10 licks
before the conditioned stimulus (licks 80-90)and 10 licks
during the conditioned stimulus (licks 90-100).
In contrast, no significant difference was observed
between the three groups in the times to complete
the 10 licks during the presentation of the conditioned
stimulus (F < 1).
A voidance
As can be seen in Figure 4 all 3 groups (cholinergic
PK, n 11; cholinergic synaptosomes, n 8;and con-
trois, n 9) acquired the avoidance response over
the 10 days of avoidance training. This was supported
by the significant main effect of days (F 9.42 df
9/225 p < 0.001). No differences were observed be-
tween the groups in acquisition of the avoidance re-
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Fig. 4. Mean percent of avoidance responses over 10 days
(20 trials/day) of rats immunized for a year with
either Torpedo cholinergic perikarya (l) (n 11),
Torpedo cholinergic synaptosomes (&) (n 8)
or adjuvant alone (O) (n 9).
T-MAZE
DAYS OF ACQUISITION
Fig. 5. Mean correct choices in a T-maze alternation test
over 11 acquisition days (8 trials/day) of rats im-
munized for a year with either Torpedo cholinergic
perikarya (e) (n 16), Torpedo cholinergic synap-
tosomes (A) (n 4) or adjuvant alone (O)(n
7). The SE bar represents one standard error derived
from the term of the ANOVA.
sponse in either the main effect of treatment or the
interaction of treatment by days (F’s < 1).
T-maze Alternation
The mean daily number of correct choices of the
three groups (cholinergic PK, n 6; cholinergic synap-
tosomes, n 4; and controls, n 7) are presented
in Fig. 5. As can be seen animals from all 3 groups
exhibited improved performance as acquisition prog-
ressed. This was supported by the significant main
effect of days (F 11.32 df 10/140 p < 0.001).
However, the cholinergic PK group demonstrated
a deficit relative to the other groups in choosing the
correct arm on the choice trials. This deficit was evi-
dent throughout the entire course of acquisition and
was supported by the significant main effect of treat-
ment (F 3.12 df 2/14 p < 0.05). No difference
was observed between the cholinergic synaptosomes
group and the controls.
EXPERIMENT 2
The results presented in Experiment suggest that
rats immunized with cholinergic PK for one year ac-
quire behavioral deficits in specific tasks involving
spatial learning. In order to characterize the rate of
development of this deficit and to examine whether
it is accompanied by brain biochemical changes, a
second group of rats was studied.
EXPERIMENTAL PROCEDURES
Preparation ofAntigens
Torpedo cholinergic PK were prepared as described
in Experiment 1.
Subjects
Male Sprague-Dawley rats were obtained and housed
as described in Experiment 1. They were immunized
subcutaneously at the age of 3 months with either
Torpedo cholinergic PK (50 /ag protein; n 32)or
adjuvant alone (controls, n 32). Further immuni-
zations were given as in Experiment 1. At 4 and 8
months following the initial immunization immuno-
blot studies were performed with sera of 15 choli-
nergic PK immunized rats and 15 controls as described
in Experiment 1. At each time point twelve of the
cholinergic PK rats with a high level of antibodies
to the 200 kD PK protein and 12 control rats with
no such antibodies were tested in the Morris swim
maze. All the animals that were tested at 4 months
completed the experiment whereas 2 controls died
during the 8 months experiment and their results were
excluded from the analysis. Nine cholinergic PK and
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9 control rats which completed the behavioral test
at 4 months were sacrificed for the biochemical study
which was performed at 6 months following the initial
immunization. The rats which completed the Morris
swim test at 8 months (10 cholinergic PK rats and
12 controls) were tested at 9 months in a T-maze al-
ternation test. One rat in each group died during the
course of the experiment and their results were ex-
cluded from the analysis. Nine rats from each group
which completed the T-maze alternation test were
sacrificed at 12 months for the biochemical study.
Morris Swim Test
The test was performed as described in Experiment
except that the analysis included only two groups
in the main effect of treatment (Cholinergic PK and
controls).
T-maze Alternation
RESULTS
Morris Swim Test
The cholinergic PK rats and the controls acquired
the swimming response at both 4 and 8 months fol-
lowing the initial immunization i.e. they exhibited
shorter response latencies as acquisition progressed.
This was supported by the significant main effect
of days (F 44.43 df 4/124 p < 0.001 at 4 months
and F 44.17 df 4/76 p < 0.001 at 8 months) and
trials (F 12.46 df 3/93 p < 0.001 at 4 months
and F 9.39 df 3/57 p < 0.001 at 8 months). The
main effect of treatment in these experiments and
in the Morris swim test performed in Experiment
(12 months) are summarized in Figure 6 which de-
picts the average log latencies of the different rat grouos
and the p values of the main effect of treatment in
each test. No difference was found between the choli-
nergic PK and the control rats at 4 months (F < 1).
The test was performed as described in Experiment
except that after the rats were tested for 10 days
(8 trials per day) by this procedure they were further
tested for 6 days in a modified paradigm. In this mo-
dified paradigm a 20 sec delay was introduced between
the information run and the test run. Analysis was
performed separately on the two stages of the expe-
riment (days 1-10 and 11-16) as in Experiment
except that only two groups were included in the
main effect of treatment (Cholinergic PK and con-
trols).
Enzyme Activity Assays
Groups of 9 cholinergic PK rats and 9 controls
were sacrificed by cervical dislocation 6 months and
12 months following the initiation of immunization.
Their brains were immediately excised and dissected
into 10 areas: frontal cortex, parietal-occipital cortex,
hippocampus, olfactory lobe, septum, striatum, hypo-
thalamus, midbrain, cerebellum and brainstem. Each
area was then homogenised (10% w/v) in ice cold 10mM
phosphate buffer, pH 7.4 and stored in aliquots
at -70C until used.
Choline acetyltransferase (CHAT) activity was mea-
sured according to Fonnum /13/ whereas acetylcholin-
esterase (ACHE) activity was assayed by the method
of Johnson and Russel/15/. The levels of each enzyme
in homogenates of brain areas of cholinergic PK and
control rats were compared by Student’s T test.
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Fig. 6. The overall mean (over 5 training days) latencies
to escape in a Morris swim test following 4 months
(A), 8 months (B) and 12 months (C) of immuniza-
tion of rats with Torpedo cholinergic perikayra
(full bars), Torpedo cholinergic synaptosomes (striped
bar) and adjuvant alone (open bars).
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At 8 months following the initiation of immunization
the cholinergic PK rats displayed longer escape laten-
cies than the controls (F 3.55, df 1/19 p 0.07),
and at 12 months they displayed significantly longer
escape latencies (F 3.28 df 2/31 p < 0.05). The
main effect of treatment was not in interaction with
either days or trials in any of the swim tests performed
(F’s < 1).
T-maze Alternation Test
The above water maze experiments suggest that
the cholinergic PK rats display some degree of im-
paired performance after 8 months of immunization.
In order to test whether their performance was also
impaired in a T-maze alternation test at this time,
the same animals were examined in this paradigm.
This experiment was performed 9 months after the
initial immunization. The daily average correct choices
of the cholinergic PK (n 11) and control (n 9)
groups over 16 days of acquisition are presented in
Figure 7. As can be seen, both groups exhibited im-
proved performance and achieved the same level of
correct choices. This was supported by the signifi-
cant main effect of days (F 8.62 df 9/162 p <
0.001) and a non significant main effect of treatment
(F < 1). It should be noted that although it seems
graphically that the cholinergic PK rats made fewer
correct choices than the controls during the first 5
days of acquisition this difference was not statistically
significant. In order to improve the sensitivity of the
T-maze paradigm a 20 seconds delay was introduced
on days 11 to 16 between the information and choice
runs. As can be seen in Fig. 7 this delay caused a severe
impairment in the performance of the cholinergic
PK rats but had no effect on that of the controls.
Analysis of the results obtained during the 6 days
of acquisition following the introduction of the delay
revealed a highly significant main effect of treatment
(F 31.5 df 1/18 p < 0.001).
Biochemical Studies
In order to examine whether the behavioral changes
manifested by the cholinergic PK rats were accom-
panied by biochemical changes in their brains, we
sacrificed 9 rats from each group (cholinergic PK and
controls) at 6 and 12 months following the initiation
of immunization and measured the weights, protein
content and ChAT and AChE activities in define
regions of their brains (frontal cortex, parietal-occi-
8.o
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5.0
delay
40-
? __, _[ I, 1, 1"
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DAYS OF ACQUISITION
Fig. 7. Mean correct choices in a T-maze alternation test
over 16 training days of rats immunized for 9 months
with Torpedo cholinergic perikarya (o) (n 11)
and of control rats immunized with adjuvant alone
(e) (n 9). The delays between the information
and choice runs were 0 sec and 20 sec on days 1--10
and 11-16 respectively. The bars on the left and
right hand sides of the figure represent one standard
error derived from the error term of the ANOVA
for days 1--10 and 11-16 respectively.
pital cortex, hippocampus, olfactory lobe, septum,
striatum, hypothalamus, midbrain, cerebellum and
brainstem). The ChAT and AChE levels thus measured
are summarized in Table 2 and Table 3 respectively.
As can be seen the levels of both enzymes in the hypo-
thalamus of cholinergic PK rats increased significantly
above the control level at 8 months (CHAT 23%, p <
0.01, AChE 19%, p < 0.05), and decreased to levels
below that of the controls at 12 months (CHAT 12%,
p < 0.05, AChE 5%, not significant). No significant
changes were observed in the ChAT activity of the
other brain areas examined. The levels of AChE ac-
tivity in the septum of cholinergic PK immunized
rats increased by 21% (p < 0.05) at 6 months and
returned to control levels at 12 months. Additional
statistically significant changes in AChE levels of the
cholinergic PK rats were observed at 12 months in
the hippocampus and striatum (a decrease of about
10%, p < 0.05) and in the olfactory lobe (an increase
of 34%; p < 0.05). The ChAT and AChE levels in
the midbrain, cerebellum and medulla-pons of choli-
nergic PK rats did not differ at any time from those
of controls. No differences were observed between
the weights and protein contents of brain areas of
the cholinergic PK and control rats.
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TABLE 2
THE EFFECTS OF IMMUNIZATION WITH TORPEDO
CHOLINERGIC CELL BODIES ON RAT BRAIN
CHOLINEACETYLTRANSFERASE LEVELS
six months twelve months
immunization immunization
control PK control PK
rats rats rats rats
(pmol/mg (% of (pmol/mg (% of
protein/min) control) protein/min) control)
hippocampus 458 + 41 97 + 9 587 + 59 98 + 5
septum 1099+ 154 113 + 15 1043 + 125 105 + 15
hypothalamus 293+ 25 123 +18"* 389 + 48 88 + 7*
posterior cortex 414 + 41 103 + 15 471+ 42 102 + 14
frontal cortex 346+ 35 110+30 428+ 30 99+14
olfactory lobe 520 + 114 95 + 28 699 + 125 90 + 29
striatum 1325 + 132 118 +25 1226 + 122 100 + 12
midbrain 506+ 35 107+ 9 503+ 50 108+ 8
cerebellum 94+ 13 103+15 78+ 6 94+14
medulla-pons 876 + 44 102 + 11 1020 + 61 98 + 10
The levels of cholineacetyltransferase in brain areas of
groups of rats immunized for either six or twelve months with
cholinergic cell bodies (PK rats) or adjuvant (control rats)
were measured as described in Experimental Procedures. Re-
suits presented are the mean + SD of 9 rats in each group.
The values of the cholinergic PK rats (mean + SD) are expressed
as % of the corresponding control values.
* p (0.05, ** p (0.01.
TABLE 3
THE EFFECTS OF IMMUNIZATION WITH TORPEDO
CHOLINERGIC CELL BODIES ON RAT BRAIN
ACETYLCHOLINESTERASE LEVELS
six months twelve months
immunization immunization
control PK control PK
rats rats rats rats
(pmol/mg (% of (pmol/mg (% of
protein/min) control) protein/min) control)
hippocampus 49 + 5 102 +12 51+ 4 91+ 7*
septum 89 + 8 121 + 20* 83 + 11 105 + 23
hypothalamus 55+ 4 119+17" 65+ 7 95+ 9
posterior cortex 32+ 3 97+14 36+ 3 91_+14
frontal cortex 31 + 2 101 + 11 33 + 3 90 + 12
olfactory lobe 48 + 10 88 + 22 36 + 5 134 + 29*
striatum 250 + 33 112 + 24 263 + 24 88 + 6*
midbrain 70 + 6 105 + 9 71 + 6 99+ 8
cerebellum 23 + 3 100 + 12 24 + 3 104 + 15
medulla-pons 61 + 3 97 + 9 73 + 7 104 + 13
The levels of acetylcholinesterase in brain areas of groups
of rats immunized for either six or twelve months with choli-
nergic cell bodies (PK rats) or adjuvant (control rats)were
measured as described in Experimental Procedures. Results
presented are the mean + SD of 9 rats in each group. The values
of the cholinergic PK rats (mean + SD) are expressed as %
of the corresponding control values.
* p ( 0.05.
DISCUSSION
The central clinical feature of AD is dementia.
Thus, any animal model attempting to replicate fea-
tures of the disease should display some behavioral
deficits. The present findings show that rats immunized
for one year with isolated perikarya of the purely
cholinergic Torpedo neurons display behavioral changes.
The cognitive deficits observed were apparent in the
Morris swim test and T-maze alternation test, both
of which monitor performance in spatial learning tasks.
In contrast, these rats showed no impairment in ge-
neral locomotor activity, in a conditioned emotional
response paradigm and in an active avoidance test.
These findings suggest that immunization with PK
induces specific cognitive deficits.
Introduction of a 20 sec delay in the T-maze al-
ternation test 9 months after the initiation of immu-
nization uncovered a marked deficit in the perform-
ance of the cholinergic PK immunized rats (Fig. 7).
This finding suggests that the behavioral deficit is
due to a specific derangement of short term memory
associated with spatial localization. It is interesting
to note that a similar delay dependent deficit in short
term memory has been demonstrated in patients with
AD /30/ and that spatial localization is also impaired
in this disease /22/. Furthermore, animal models of
AD involving lesions of the cholinergic nuclei of the
basal forebrain likewise produce spatial localization
deficits and a working memory deficit indicative of
a decreased short term memory/38/.
The rats developed a maximal immunological re-
sponse to the cholinergic PK antigens after 2 months
of immunization. In contrast, examination of the
rate of onset of the deficit in the Morris swim test
of immunized rats revealed no behavioral deficit at
4 months, a detectable impairment at 8 months and
a significant deficit after 12 months of immunization
(Fig. 6). A similar time course was observed in the
performance of rats in a T-maze alternation test. The
rats immunized for 9 months showed only a small
and insignificant deficit in performing the test while
those immunized for 14 months displayed a clear
deficit in the same paradigm (Figs. 5 and 7). It thus
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seems that the behavioral deficits develop at a sub-
stantially slower rate than the immunological response
to the cholinergic PK antigens. This finding may be
due to the greater susceptibility of older rats to an
immune mediated insult or may indicate the slowly
progressive nature of this insult. Previous studies on
the entry of IgG into normal rat brain have indicated
that this is indeed a relatively slow process dependent
on retrograde axonal transport /10, 24/. The relevance
of this mechanism to the present findings and the
influence of other mechanisms on the rate of deve-
lopment of the cognitive deficit remain to be deter-
mined.
The finding that the behavioral deficits are induced
by immunization with Torpedo cholinergic PK but
not with the purified nerve terminals of the same neu-
rons suggests that these deficits are due to an immune
response specific to Torpedo cholinergic PK. Exami-
nation of the antibodies specific to rats immunized
with cholinergic PK revealed antibodies to three anti-
gens with apparent molecular weights of respectively
20, 26, and 200 kD. Neither rats immunized with
cholinergic synaptosomes nor the control rats deve-
loped antibodies to these antigens (Fig. 1). Some evi-
dence exists to indicate that, of these three antigens,
the immune response to the 200 kD protein is rele-
vant to the cognitive deficit. Firstly, immunization
of another strain of rats (Wistar) with Torpedo choli-
nergic PK resulted in production of antibodies to the
20 and 26 kD polypeptides but not to the 200 kD
protein and did not cause any apparent deficit in per-
formance in a T-maze alternation test (not shown).
Secondly, AD patients also have specific antibodies
which bind to the 200 kD protein of Torpedo choli-
nergic PK but not antibodies to the 20 and 26 kD
polypeptides /4/. The hypothesis that the observed
cognitive deficits are due to a specific immune reac-
tion to the Torpedo cholinergic 200 kD protein is
currently being investigated in our laboratories by
experiments in which rats are immunized for a oro-
longed period with the purified protein and the re-
sulting immunological and behavioral responses are
examined.
The cellular and biochemical mechanisms under-
lying the immunologically induced behavioral changes
in the rats are not known. The findings that ChAT
and AChE levels change in some brain areas show
that the central nervous system, and in particular cen-
tral cholinergic neurons are affected by the immu-
nization. It is interesting to note that not all central
cholinergic neurons seem affected. The midbrain,
cerebellum and brainstem, areas which are relatively
preserved in AD, show no biochemical changes fol-
lowing immunization of the rats with cholinergic PK.
Biochemical changes were found in the septum, hippo-
campus, striatum (which in the rodent contains the
equivalent of the nucleus basalis of Meynert), cortex
and hypothalamus of the PK immunized rats. These
areas are involved in learning and memory and have
all been reported to be affected in the brains of AD
patients. It should be noted that in some of these
brain areas (e.g. hypothalamus and septum) the de-
crease in enzymatic activity observed after one year
was preceded by a transient increase (see Tables 2
and 3). Increases of ChAT activity per cholinergic
neuron in the nucleus basalis of Meynert and in AChE
activity in the cortex have previously been observed
in AD patients /40/. It is important however to stress
that the nature and extent of the changes in ChAT
and AChE activities reported in the present study
are unlike the profound reduction in ChAT activity
found in the brains of AD patients. It remains
to be seen whether the presently observed neuro-
chemical changes in the brains of the immunized rats
represent an early phase of a pathogenetic process
similar to AD and whether immunization for more
than one year will induce more severe biochemical
as well as histological changes and the extent of their
similarity to those found in AD.
In summary, the findings presented show that rats
immunized with cholinergic PK gradually develop
behavioral deficits and impairments in short term
memory. These findings indicate that immunization
with cholinergic PK antigens induces specific brain
neuronal dysfunction in rats and support the provo-
cative hypothesis that the antibodies to cholinergic
antigens found in patients with AD may also play
a role in the degeneration of central cholinergic neu-
rons in this disease.
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